1841PRefining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
Matos Garcia, I, García Ruiz, A, Martin-Liberal, J, Hierro, C, Ochoa De Olza Amat, M, Viaplana, C, Mur, G, Vieito Villar, M, Brana, I, Azaro, A, Perez, C, Rodriguez Freixinos, V, Argiles, G, Oliveira,Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy303.011
Date:
October, 2018
File:
PDF, 76 KB
english, 2018